Please ensure Javascript is enabled for purposes of website accessibility

Guardant Health Dips on Pricing of Equity Offering

By Jim Crumly – Oct 7, 2020 at 3:14PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Softbank is offering shares of the precision oncology company at a (temporary) bargain price.

Guardant Health (GH 2.67%) opened lower Wednesday after the company announced the pricing of shares being offered for public sale by SoftBank Investment Advisers, a unit of SoftBank Group.

The Japanese technology conglomerate is offering 7 million shares of Guardant Health in an underwritten public offering at $102, 7% below the price the stock closed at Tuesday, and has granted the underwriter a 30-day option to purchase an additional 700,000 shares at that price. The stock dipped to $101 in the morning, then recovered most of its losses. Shares were trading for around $107.80 as of 3 p.m. EDT, down by about 1.9% on the day.

Pile of $100 bills.

Image source: Getty Images.

The sale by SoftBank was no surprise, plans for it having been disclosed in June when the company announced a secondary offering of 3.75 million shares to raise money for its own purposes. SoftBank has completed a number of stock sales this year as it raises cash and pays off debt. Notable among those moves was its massive $40 billion deal to sell Arm Holdings to chipmaker NVIDIA in September. The market on Wednesday was apparently concerned about the pricing of Guardant's shares, but the growth stock was selling for $102 just three weeks ago.

The pioneer in liquid biopsy blood tests to detect and identify cancer won't receive any of the proceeds from SoftBank's offering, but the company has $938 million in cash and no debt on its balance sheet after its own share offering. When asked on the latest conference call about the possibility of acquisitions in the future, Guardant's CEO said the company continues to look for opportunities.

Jim Crumly owns shares of Guardant Health and NVIDIA. The Motley Fool owns shares of and recommends Guardant Health and NVIDIA. The Motley Fool has a disclosure policy.

Stocks Mentioned

Guardant Health Stock Quote
Guardant Health
$53.81 (2.67%) $1.40
SoftBank Group Corp. Stock Quote
SoftBank Group Corp.
$22.54 (1.99%) $0.44

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.